Otologic Pharmaceutics' Unattributed VC Round

Otologic Pharmaceutics raised a round of funding on September 28, 2010.

Otologic Pharmaceutics (OPI) is a development-stage biopharmaceutical company committed to developing and commercializing novel pharmacological solutions and approaches to treat hearing disorders. OPI…

Articles about Otologic Pharmaceutics' Unattributed VC Round: